Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage biotechnology company pioneering a new and differentiated class of…
AstraZeneca and Merck’s Selumetinib Would Become the First Medicine Indicated for the Treatment of Certain Pediatric Patients with NF1 Plexiform…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Douglas L. Braunstein is stepping…
− Growth in the near- and medium-term will also be driven by the expansion of Takeda’s current 14 global growth…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global diabetic neuropathy drugs market size will grow by USD 866.72 million during 2019-2023. This market report provides…
BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S today announced that Birgitta Stymne Göransson has been elected member of the company’s Board of…
Highlights: Trial meets its Primary Endpoint with 39% ORR (95%CI 22%-58%) in patients with advanced PEComa – a rare sarcoma…
More than 2,000 industry leaders learned best practices and advanced the digital transformation of life sciences Medidata Customer Award Winners…
– Preliminary Anti-tumor Activity Observed in Initial Diffuse-type TGCT Patients Treated with DCC-3014 in Ongoing Phase 1 Study – –…
Phase II Study of DM199 in Chronic Kidney Disease Commences Screening REMEDY Phase II Study of DM199 in Acute Ischemic…